Stock ETON ETON PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Eton Pharmaceuticals, Inc.

Equities

ETON

US29772L1089

Market Closed - Nasdaq
Other stock markets
 04:30:01 2024-05-03 pm EDT 		5-day change 1st Jan Change
3.71 USD -1.07% Intraday chart for Eton Pharmaceuticals, Inc. +7.54% -15.30%
Apr. 30 Sector Update: Health Care Stocks Gain in Afternoon Trading MT
Apr. 30 Eton Pharmaceuticals Submits New Drug Application to FDA For ET-400 MT

Evolution of the average Target Price on Eton Pharmaceuticals, Inc.

Price target over the last 5 years

History of analyst recommendation changes

f3917b81b3b9c73ac5936.VH8OzdAym--oxVljy3ynmlYLld0aYeYMgJ061nVH13A.J0pntYRdtsLkjykthCjE_m4-xqlqAJRi5ddQpSF-4QAwNVf94Uuqi8WaPg~73a06e68d094a13878e2b01e5bb7942b

Analyst Recommendations on Eton Pharmaceuticals, Inc.

HC Wainwright Adjusts Eton Pharmaceuticals Price Target to $10 From $9, Maintains Buy Rating MT
HC Wainwright Trims Price Target on Eton Pharmaceuticals to $9 From $10, Maintains Buy Rating MT
HC Wainwright Adjusts Eton Pharmaceuticals' Price Target to $10 From $9, Keeps Buy Rating MT
HC Wainwright Adjusts Eton Pharmaceuticals' Price Target to $9 from $11, Keeps Buy Rating MT
B. Riley Trims Eton Pharmaceuticals' Price Target to $9 from $10 But Notes 'Solid' Growth Prospects Despite Partner Setback, Keeps Buy Rating MT
HC Wainwright Adjusts Eton Pharmaceuticals' Price Target to $11 From $14, Keeps Buy Rating MT
ETON PHARMACEUTICALS : B. Riley Resumes Eton Pharmaceuticals at Buy with $10 PT, Sees Potential in 'Robust' Pipeline Despite Regulatory Challenges, Related Delays MT
ETON PHARMACEUTICALS : B. Riley Lowers Eton Pharmaceuticals' PT to $11 from $13 on Lowered Probability of Success for DS100, Keeps Buy Rating MT
ETON PHARMACEUTICALS : HC Wainwright Adjusts Eton Pharmaceuticals's Price Target to $15 From $20, Keeps at Buy MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
3.71 USD
Average target price
10 USD
Spread / Average Target
+169.54%
High Price Target
10 USD
Spread / Highest target
+169.54%
Low Price Target
10 USD
Spread / Lowest Target
+169.54%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Eton Pharmaceuticals, Inc.

HC Wainwright
B. Riley

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ETON Stock
  4. Consensus Eton Pharmaceuticals, Inc.